Trial information
A Study of Long-Term Interferon Therapy in Patients with Hepatitis C
Status: Completed
Protocol number: 00-DK-0186
Company division: Diagnostic
Official Scientific Title: Hepatitis C antiviral long-term treatment against cirrhosis (HALT-C)
Brief summary: This study will investigate whether long-term antiviral therapy with interferon can prevent liver disease from progressing in patients with chronic hepatitis C infection
Study type: Interventional study
Condition: Hepatitis C, Chronic
Intervention name: Amplicor GT HCV Monitor
Inclusion criteria:
hepatitis C infection, non-responsive to previous HCV therapy
Exclusion criteria:
hepatitis B infection
autoimmune hepatitis
HIV infection
intolerant of interferon treatment
Gender: Males or Females
Age limits: Min: 18 Years Max: 99 Years
Accepts healthy volunteers: No
Anticipated start date: January, 2006
Trial registration date: 03/16/2006
Date last updated: 12/2/2008
Link to trial result
This trial was conducted at the following locations:
United States
- Irvine, CA
- Los Angeles, CA
- Denver, CO
- Bethesda, MD
- Boston, MA
- Worcester, MA
- Ann Arbor, MI
- St. Louis, MO
- Dallas, TX
- Richmond, VA
